Sélim Corm

2.7k total citations
44 papers, 1.4k citations indexed

About

Sélim Corm is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Sélim Corm has authored 44 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hematology, 25 papers in Genetics and 12 papers in Rheumatology. Recurrent topics in Sélim Corm's work include Chronic Myeloid Leukemia Treatments (26 papers), Chronic Lymphocytic Leukemia Research (25 papers) and Eosinophilic Disorders and Syndromes (12 papers). Sélim Corm is often cited by papers focused on Chronic Myeloid Leukemia Treatments (26 papers), Chronic Lymphocytic Leukemia Research (25 papers) and Eosinophilic Disorders and Syndromes (12 papers). Sélim Corm collaborates with scholars based in France, United States and Canada. Sélim Corm's co-authors include Claude Preudhomme, Hervé Dombret, Catherine Roche‐Lestienne, Bruno Quesnel, Lydia Roy, Andreas Hochhaus, Jeffrey H. Lipton, François Guilhot, Céline Berthon and Timothy P. Hughes and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Molecular Therapy.

In The Last Decade

Sélim Corm

42 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sélim Corm France	18	1.0k	715	444	232	199	44	1.4k
Barbara Izzo Italy	15	1.3k 1.2×	812 1.1×	515 1.2×	339 1.5×	364 1.8×	40	1.5k
Fábio Pires de Souza Santos Brazil	18	707 0.7×	657 0.9×	247 0.6×	477 2.1×	71 0.4×	73	1.2k
Fumiharu Yagasaki Japan	20	1.2k 1.2×	333 0.5×	263 0.6×	526 2.3×	607 3.1×	61	1.5k
Anna Serra Italy	21	658 0.6×	460 0.6×	113 0.3×	475 2.0×	237 1.2×	64	1.2k
Jan Van Droogenbroeck Belgium	10	507 0.5×	401 0.6×	234 0.5×	158 0.7×	57 0.3×	31	789
Robert Schoch Germany	12	1.7k 1.7×	604 0.8×	54 0.1×	972 4.2×	352 1.8×	21	2.3k
Zalmen A. Arlin United States	19	577 0.6×	227 0.3×	34 0.1×	303 1.3×	345 1.7×	53	1.1k
Hervé Dombret France	10	640 0.6×	142 0.2×	89 0.2×	255 1.1×	432 2.2×	11	911
Sabine Knipp Germany	12	1.2k 1.1×	535 0.7×	36 0.1×	521 2.2×	192 1.0×	20	1.4k
Hélène Jouault France	16	369 0.4×	259 0.4×	73 0.2×	240 1.0×	61 0.3×	33	801

Countries citing papers authored by Sélim Corm

Since Specialization

Citations

This map shows the geographic impact of Sélim Corm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sélim Corm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sélim Corm more than expected).

Fields of papers citing papers by Sélim Corm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sélim Corm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sélim Corm. The network helps show where Sélim Corm may publish in the future.

Co-authorship network of co-authors of Sélim Corm

This figure shows the co-authorship network connecting the top 25 collaborators of Sélim Corm. A scholar is included among the top collaborators of Sélim Corm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sélim Corm. Sélim Corm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Belhabri, Amine, Yves Bertrand, Catherine Sebban, et al.. (2019). Pattern of Care and Outcomes of Adolescent and Young Adults with Lymphoma Treated in the Rhône-Alpes Region. Journal of Adolescent and Young Adult Oncology. 8(6). 684–696.

Lengliné, Étienne, Bernard Drénou, Pierre Péterlin, et al.. (2017). Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia. Haematologica. 103(2). 212–220. 45 indexed citations

Berthon, Céline, Michaëla Fontenay, Sélim Corm, et al.. (2013). Metabolites of tryptophan catabolism are elevated in sera of patients with myelodysplastic syndromes and inhibit hematopoietic progenitor amplification. Leukemia Research. 37(5). 573–579. 26 indexed citations

Gorin, Norbert Claude, Françoise Isnard, Laurent Garderet, et al.. (2013). Administration of alemtuzumab and G‐CSF to adults with relapsed or refractory acute lymphoblastic leukemia: results of a phase II study. European Journal Of Haematology. 91(4). 315–321. 20 indexed citations

Berthon, Céline, Sélim Corm, Jason Gay, et al.. (2011). Vancomycin serum concentration during febrile neutropenia in patients with acute myeloid leukemia. Médecine et Maladies Infectieuses. 41(12). 652–656. 15 indexed citations

Sibon, David, Giovanna Cannas, Thomas Prébet, et al.. (2011). Lenalidomide in lower‐risk myelodysplastic syndromes with karyotypes other than deletion 5q and refractory to erythropoiesis‐stimulating agents. British Journal of Haematology. 156(5). 619–625. 29 indexed citations

Domenech, Carine, Xavier Thomas, Sylvie Chabaud, et al.. (2011). l‐asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005‐01 randomized trial. British Journal of Haematology. 153(1). 58–65. 113 indexed citations

Corm, Sélim, Laurent Roche, Jean‐Baptiste Micol, et al.. (2011). Changes in the dynamics of the excess mortality rate in chronic phase-chronic myeloid leukemia over 1990-2007: a population study. Blood. 118(16). 4331–4337. 22 indexed citations

Leprêtre, Frédéric, Sélim Corm, Franck E. Nicolini, et al.. (2010). Genomic characterization of Imatinib resistance in CD34+ cell populations from chronic myeloid leukaemia patients. Leukemia Research. 35(4). 448–458. 10 indexed citations

10.

Sibon, David, Giovanna Cannas, Fiorenza Barraco, et al.. (2010). Lenalidomide (LEN) In Lower-Risk Myelodysplastic Syndromes (MDS) with Karyotypes Other Than Deletion 5q and Refractory to Erythropoiesis-Stimulating Agents (ESAs). Blood. 116(21). 4002–4002. 2 indexed citations

11.

Mazingue, Françoise, Florence Pasquier, François Nosten, et al.. (2010). Invasive fungal infections: epidemiology and analysis of antifungal prescriptions in onco-haematology. Journal of Clinical Pharmacy and Therapeutics. 36(2). 152–160. 27 indexed citations

12.

Idziorek, Thierry, Sélim Corm, Dominique Hétuin, et al.. (2008). BCR-ABL mutants spread resistance to non-mutated cells through a paracrine mechanism. Leukemia. 22(4). 791–799. 33 indexed citations

13.

Richebourg, Steven, Virginie Éclache, Christine Pérot, et al.. (2008). Mechanisms of genesis of variant translocation in chronic myeloid leukemia are not correlated with ABL1 or BCR deletion status or response to imatinib therapy. Cancer Genetics and Cytogenetics. 182(2). 95–102. 33 indexed citations

14.

Douet‐Guilbert, Nathalie, J L Laï, Audrey Basinko, et al.. (2008). Fluorescence in situ hybridization characterization of ider(20q) in myelodysplastic syndrome. British Journal of Haematology. 143(5). 716–720. 13 indexed citations

15.

Corm, Sélim, Agnès Daudignon, Sandrine Geffroy, et al.. (2008). Cryptic and partial deletions of PRDM16 and RUNX1 without t(1;21)(p36;q22) and/or RUNX1–PRDM16 fusion in a case of progressive chronic myeloid leukemia: A complex chromosomal rearrangement of underestimated frequency in disease progression?. Genes Chromosomes and Cancer. 47(12). 1110–1117. 13 indexed citations

16.

Nicolini, Franck E., Sandrine Hayette, Sélim Corm, et al.. (2007). Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a T315I BCR-ABL mutation. Haematologica. 92(9). 1238–1241. 51 indexed citations

17.

Nicolini, Franck E., Sélim Corm, Q.H. Le, et al.. (2006). Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(ϕ)-LMC GROUP). Leukemia. 20(6). 1061–1066. 154 indexed citations

18.

Corm, Sélim, Ariane Leroyer, Mathieu Wémeau, et al.. (2006). A Retrospective 20-Year Survey of the Incidence of Chronic Myeloid Leukemia in the Northern France Region.. Blood. 108(11). 4798–4798. 2 indexed citations

19.

Saudemont, Aurore, Sélim Corm, Thomas J. Wickham, Dominique Hétuin, & Bruno Quesnel. (2005). Induction of leukemia-specific CD8+ cytotoxic t cells with autologous myeloid leukemic cells maturated with a fiber-modified adenovirus encoding TNF-α. Molecular Therapy. 11(6). 950–959. 9 indexed citations

20.

Vereecque, Rodolphe, Aurore Saudemont, Sélim Corm, et al.. (2004). Efficient generation of antileukemic autologous T cells by short-term culture and ?-irradiation of myeloid leukemic cells. Cancer Immunology Immunotherapy. 53(9). 793–8. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact